Auteur J. DUPOUY

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Actualités dans la prise en charge du trouble de l'usage des opiacés en médecine générale

J. DUPOUY | 2018
Dans Courrier des Addictions (Le) (Vol.20, n°3, Juillet-août-septembre 2018) Article : Périodique

FRANÇAIS : La prise en charge du patient ayant un trouble de l'usage des opiacés (TUO) en médecine générale a permis depuis les années 90 la prise en charge de la majorité des patients sous médicament de substitution aux opiacés (MSO) avec des [...]

Plus d'info

Ajouter à la sélection

Barriers and expectations of adolescents regarding the identification and management of their psychoactive substance use by their general practitioner

F. FORTIN ; S. ROCHE ; J. DUPOUY ; P. BERNARD ; J. LACHAL ; C. LAMBERT ; C. LAPORTE | 2022
Dans International Journal of Environmental Research and Public Health (Vol.19, n°20, October 2022) Article : Périodique

AIMS: General practitioners (GPs), who are the most frequently consulted health professionals by adolescents, play a key role in screening for psychoactive substance (PAS) use. The purpose of our study was to determine the barriers and expectati[...]

Plus d'info

Ajouter à la sélection

Lien externe

Barriers and facilitators to the involvement of general practitioners in the prescription of buprenorphine

L. T. GIMENEZ ; D. L. BONIS ; M. MOREL ; A. PALMARO ; L. DASSIEU ; J. DUPOUY | 2024
Dans Journal of Substance Use and Addiction Treatment (Vol.156, January 2024) Article : Périodique

Introduction: France has one of the highest opioid agonist treatment (OAT) coverage rates in the world. French general practitioners (GPs) are providing the majority of prescriptions. However, a fall in the number of GPs initiating buprenorphine[...]

Plus d'info

Ajouter à la sélection

Lien externe

Buprenorphine deregulation as an opioid crisis policy response - A comparative analysis between France and the United States

A. SUD ; K. CHIU ; J. FRIEDMAN ; J. DUPOUY | 2023
Dans International Journal of Drug Policy (Vol.120, October 2023) Article : Périodique

Background: In passing the Maintstreaming Addiction Treatment Act, the United States has abolished its federal X waiver, considered a major barrier to the wider buprenorphine prescribing needed to respond to opioid-related harms. Advocates for t[...]

Plus d'info

Ajouter à la sélection

Lien externe

Discussing alcohol use with the GP: a qualitative study

S. COSTE ; L. GIMENEZ ; A. COMES ; X. ABDELNOUR ; J. DUPOUY ; E. ESCOURROU | 2020
Dans BJGP Open (Vol.4, n°2, June 2020) Article : Périodique

BACKGROUND: Despite most GPs recognising their role in the early diagnosis of alcohol use disorder (AUD), only 23% of GPs routinely screen for alcohol use. One reason GPs report for not screening is their relationship with patients; questions re[...]

Plus d'info

Ajouter à la sélection

Lien externe

Does urine drug abuse screening help for managing patients? A systematic review

J. DUPOUY ; V. MÉMIER ; H. CATALA ; M. LAVIT ; S. OUSTRIC ; M. LAPEYRE-MESTRE | 2014
Dans Drug and Alcohol Dependence (Vol.136, March 2014) Article : Périodique

BACKGROUND: In the field of addiction, assessment of psychoactive substance use is a key element. Nevertheless, self-reports and clinical examination underestimate the use of psychoactive substances. The implementation of urine drug screening te[...]

Plus d'info

Ajouter à la sélection

Effectiveness of drug tests in outpatients starting opioid substitution therapy

J. DUPOUY ; L. DASSIEU ; R. BOURREL ; J. C. POUTRAIN ; S. BISMUTH ; S. OUSTRIC ; M. LAPEYRE-MESTRE | 2013
Dans Journal of Substance Abuse Treatment (Vol.44, n°5, May-June 2013) Article : Périodique

We aimed to assess the effectiveness of drug tests for treatment retention in outpatients starting opioid substitution therapy. A retrospective cohort was created from the data of the French health insurance system database for the Midi-Pyrene[...]

Plus d'info

Ajouter à la sélection

GPs' practices when prescribing buprenorphine in primary care: A survey among the Sentinelles network

B. LEPINE ; M. DEBIN ; L. DASSIEU ; L. GIMENEZ ; A. PALMARO ; C. PONTE ; M. SWITAL ; M. LAPEYRE-MESTRE ; T. BLANCHON ; J. DUPOUY | 2024
Dans Therapies (Vol.79, n°6, Novembre-Décembre 2024) Article : Périodique

Introduction: France is a leading country for opioid agonist treatment providing, with a predominance of buprenorphine. General practitioners (GPs) are the main prescribers of buprenorphine, but they seem to be less involved over the last 10 yea[...]

Plus d'info

Ajouter à la sélection

Lien externe

Impact of pregnancy on psychoactive substance use among women with substance use disorders recruited in addiction specialized care centers in France

L. POCHARD ; J. DUPOUY ; E. FRAUGER ; A. GIOCANTI ; J. MICALLEF ; M. LAPEYRE-MESTRE ; French Addictovigilance Network | 2018
Dans Fundamental and Clinical Pharmacology (Vol.32, n°2, April 2018) Article : Périodique

Pregnancy can be a motivation for decrease in drug abusing but may also represent a period of high vulnerability for relapse. We aimed to assess psychoactive substance use among women with substance use disorders followed in addiction care cente[...]

Plus d'info

Ajouter à la sélection

Implication des médecins généralistes dans la prescription de buprénorphine en soins primaires

J. DUPOUY | 2022
Dans Politiques des drogues (n°3, Novembre 2022) Article : Périodique

Plus d'info

Ajouter à la sélection

Lien externe

On-site drugs of abuse urinary screening tests for the management of opiate-addicted patients: a survey among French general practitioners

J. DUPOUY ; S. BISMUTH ; S. OUSTRIC ; M. LAPEYRE-MESTRE | 2012
Dans European Addiction Research (Vol.18, n°4, June 2012) Article : Périodique

In France, opiate-addicted patients are mainly managed by general practitioners (GPs). Because on-site abuse drugs urinary screening tests (ODUTs) are now on the market, we investigated French GPs' knowledge and practices concerning drug tests w[...]

Plus d'info

Ajouter à la sélection

Patterns of gabapentin and pregabalin use and misuse: Results of a population-based cohort study in France

D. DRIOT ; E. JOUANJUS ; S. OUSTRIC ; J. DUPOUY ; M. LAPEYRE-MESTRE | 2019
Dans British Journal of Clinical Pharmacology (Vol.85, n°6, June 2019) Article : Périodique

AIMS: The aim of this study was to assess the use and factors associated with the misuse of gabapentin and pregabalin in the general French population, through a cohort study in the EGB (General Sample of Beneficiaries), a national representativ[...]

Plus d'info

Ajouter à la sélection

Prescribing buprenorphine for opioid use disorder in primary care: A survey of French general practitioners in the Sentinelles network

B. LEPINE ; M. DEBIN ; L. DASSIEU ; L. GIMENEZ ; A. PALMARO ; C. PONTE ; M. SWITAL ; M. LAPEYRE-MESTRE ; T. BLANCHON ; J. DUPOUY | 2022
Dans Journal of Substance Abuse Treatment (Vol.143, December 2022) Article : Périodique

Introduction: Although opioid substitution coverage in France is high and patient care with buprenorphine is mainly managed by general practitioners (GPs), buprenorphine sales have been decreasing since 2011, suggesting that French GPs are presc[...]

Plus d'info

Ajouter à la sélection

Lien externe

Primary care of opioid use disorder: The end of "the French model"?

J. DUPOUY ; S. MAUMUS-ROBERT ; Y. MANSIAUX ; A. PARIENTE ; M. LAPEYRE-MESTRE | 2020
Dans European Addiction Research (Vol.26, n°6, November 2020) Article : Périodique

BACKGROUND: In France, most patients with opioid use disorder (OUD) have been treated by buprenorphine, prescribed by general practitioners (GP) in private practice since 1996. This has contributed to building a 'French model' facilitating acces[...]

Plus d'info

Ajouter à la sélection

Teaching basic knowledge on substance use disorders: The impact of e-learning on health professionals

E. JOUANJUS ; M. LAPEYRE-MESTRE ; M. NODOT ; A. ROUSSIN ; N. FRANCHITTO ; J. P. BOYES ; N. NASR ; S. OUSTRIC ; J. DUPOUY | 2019
Dans Clinical Therapeutics (Vol.41, n°10, October 2019) Article : Périodique

Purpose: Recent evolution toward a medical perspective on patients with substance use disorders (SUDs) has led to a lack of medical training in substance abuse. To increase this knowledge, a distance learning course ("e-learning") was implemente[...]

Plus d'info

Ajouter à la sélection